| 产品名称 | ReVacc Scientific X40H97 | Zika Virus Reporter Virus Particle (RVP) with Renilla Luciferase Reporter |
|---|---|
| 目录号 | X40H97 |
| 别名 | Zika Virus Reporter Virus Particle (RVP) with Renilla Luciferase Reporter |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| X40H97 | 200 μl; 1000 μl | 咨询 | 咨询 |
ReVacc Scientific X40H97 | Zika Virus Reporter Virus Particle (RVP) with Renilla Luciferase Reporter
品名：Zika Virus Reporter Virus Particle (RVP) with Renilla Luciferase Reporter
货号：X40H97
品牌：ReVacc Scientific
规格：200 μl; 1000 μl
产品描述
Organism：Zika virus
Reporter virus particles (RVPs) package the capsid-preMembrane-envelope (C-prM-E) gene construct of ZIKV (GenBank: KU321639.1, SPH2015 strain) and a Renilla luciferase reporter. As the wild typed Zika virus is handled under BSL-2 precautions, this Zika virus RVP can be handled using BSL-2 containment practices. Infection of cells with this RVP carrying Renilla luciferase reporter results in high level Renilla luciferase activity. See our titration result showing that the starting 2-fold diluted RVP-infected target cells (Vero) generates signal ~ 100,000-fold higher than uninfected control (cell alone as background in blue). We also evaluated the neutralizing activity of two published monoclonal antibodies (mAbs) – domain Ⅲ specific ZV67 and quaternary EDE1-C8. See figure
